Abstract

The renin-aldosterone axis was evaluated by captopril test in 22 normotensive normoalbuminuric insulin-dependent diabetes mellitus (IDDM) patients with and without glomerular hyperfiltration. Patients were divided into those with glomerular hyperfiltration (Hf-IDDM) and with normal glomerular filtration rate (GFR; Nf-IDDM) according to the upper limit of GFR (134.7 ml/min per 1.73 m 2). Sixteen normal individuals were also studied. GFR was measured by the 51Cr-EDTA single injection method, extracellular fluid volume as the distribution volume of 51Cr-EDTA, and blood volume using 51Cr-sodium chromate-labelled red blood cells. Twenty-five mg of captopril were administered per os and plasma renin activity (PRA; RIA), plasma aldosterone (RIA) and blood pressure were measured at 0 and 120 min post-captopril. PRA at time zero (Hf-IDDM = 2.4 ± 1.7; Nf-IDDM = 2.5 ± 1.9; controls = 1.0 ± 0.6 ng/ml/h) and at 120 min (Hf-IDDM = 9.9 ± 8.3; Nf-IDDM = 11.2 ± 8.9; controls = 5.4 ± 5.7 ng/ml/h) was higher in IDDM patients than in controls ( P = 0.01). The increase of PRA was similar in patients (Hf-IDDM = 7.5 ± 7.3, and Nf-IDDM = 8.7 ± 7.2 ng/ml/h) and controls (4.4 ± 5.3 ng/ml/h). There was no difference in PRA levels between Hf-IDDM and Nf-IDDM patients. PRA did not correlate with GFR, aldosterone, blood pressure, blood volume, duration of diabetes, 24-h urinary sodium and metabolic control indexes. Plasma aldosterone and the magnitude of its decrease after captopril was similar among patients and controls. Captopril induced a greater reduction of systolic blood pressure in patients (Hf-IDDM = 12.3 ± 6.9 mmHg; Nf-IDDM = 11.1 ± 7.3 mmHg) than in controls (5.4 ± 5.2 mmHg) ( P = 0.01). No difference was found between Hf-IDDM and Nf-IDDM patients. In conclusion, normoalbuminuric IDDM patients, irrespective of glomerular hyperfiltration, presented increased levels of PRA and larger blood pressure response to captopril as compared to normal individuals.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.